| 4267- | Caff, | Caffeine‐mediated BDNF release regulates long‐term synaptic plasticity through activation of IRS2 signaling |
| - | in-vivo, | NA, | NA |
| 1206- | Caff, | Caffeine inhibits TGFβ activation in epithelial cells, interrupts fibroblast responses to TGFβ, and reduces established fibrosis in ex vivo precision-cut lung slices |
| - | in-vitro, | NA, | NA | - | ex-vivo, | NA, | NA |
| 1205- | Caff, | immuno, | Caffeine-enhanced anti-tumor activity of anti-PD1 monoclonal antibody |
| - | in-vivo, | Melanoma, | B16-F10 |
| 1653- | Caff, | Higher Caffeinated Coffee Intake Is Associated with Reduced Malignant Melanoma Risk: A Meta-Analysis Study |
| - | Review, | Melanoma, | NA |
| 4161- | Caff, | Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats |
| - | in-vivo, | AD, | NA |
| 5778- | Calc, | VitD3, | Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies |
| - | Study, | CRC, | NA |
| 5777- | Calc, | Calcium intake and colorectal cancer risk: dose-response meta-analysis of prospective observational studies |
| - | Study, | CRC, | NA |
| 5775- | Calc, | Calcium Intake and Risk of Colorectal Cancer in the NIH-AARP Diet and Health Study |
| - | Study, | CRC, | NA |
| 5776- | Calc, | Calcium |
| - | Review, | Var, | NA |
| 5779- | Calc, | Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials |
| - | Study, | CRC, | NA |
| 5842- | CAP, | Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses |
| - | Review, | Nor, | NA | - | Review, | Diabetic, | NA |
| 5841- | CAP, | The red pepper’s spicy ingredient capsaicin activates AMPK in HepG2 cells through CaMKKβ |
| - | in-vitro, | HCC, | HepG2 |
| 5840- | CAP, | Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network |
| - | Review, | Var, | NA |
| 5839- | CAP, | Capsaicin: beyond TRPV1 |
| - | Review, | Var, | NA |
| 5838- | CAP, | Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR Pathway |
| - | in-vitro, | NPC, | NA |
| 5837- | CAP, | Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression |
| - | in-vitro, | lymphoma, | PEL |
| 5836- | CAP, | In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway |
| - | vitro+vivo, | PC, | AsPC-1 | - | in-vitro, | PC, | Bxpc-3 |
| 5835- | CAP, | Capsaicin and dihydrocapsaicin induce apoptosis in human glioma cells via ROS and Ca2+-mediated mitochondrial pathway |
| - | in-vitro, | GBM, | U251 |
| 5834- | CAP, | Capsaicin and TRPV1: A Novel Therapeutic Approach to Mitigate Vascular Aging |
| - | Study, | Nor, | NA |
| 5833- | CAP, | Capsaicin: From Plants to a Cancer-Suppressing Agent |
| - | Review, | Var, | NA |
| 5832- | CAP, | Capsaicin induces cell cycle arrest and apoptosis in human KB cancer cells |
| - | in-vitro, | Oral, | KB |
| 5831- | CAP, | Unraveling TRPV1’s Role in Cancer: Expression, Modulation, and Therapeutic Opportunities with Capsaicin |
| 5830- | CAP, | Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro |
| - | in-vitro, | Nor, | HK-2 |
| 5825- | CAP, | Bioavailability of capsaicin and its implications for drug delivery |
| - | Review, | Var, | NA | - | Review, | Arthritis, | NA | - | Review, | Obesity, | NA |
| 5829- | CAP, | Anti-cancer activity of capsaicin and its analogs in gynecological cancers |
| - | Review, | Var, | NA |
| 5828- | CAP, | Capsaicin: a novel radio-sensitizing agent for prostate cancer |
| - | vitro+vivo, | Pca, | LNCaP | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 |
| 5827- | CAP, | The Effect of Topical Capsaicin 8% on Pain in Chemotherapy-induced Peripheral Neuropathy |
| - | Trial, | Var, | NA |
| 5826- | CAP, | Capsaicin induces mitochondrial dysfunction and apoptosis in anaplastic thyroid carcinoma cells via TRPV1-mediated mitochondrial calcium overload |
| - | in-vitro, | Thyroid, | NA |
| 5824- | CAP, | Pharmacokinetic and the effect of capsaicin in Capsicum frutescens on decreasing plasma glucose level |
| - | Study, | Diabetic, | NA |
| 5844- | CAP, | Non-pungent long chain capsaicin-analogs arvanil and olvanil display better anti-invasive activity than capsaicin in human small cell lung cancers |
| - | in-vitro, | Lung, | DMS114 |
| 5861- | CAP, | Anticancer Properties of Capsaicin Against Human Cancer |
| - | Review, | Var, | NA |
| 5860- | CAP, | Beneficial Effects of Capsaicin in Disorders of the Central Nervous System |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 5859- | CAP, | Are We Ready to Recommend Capsaicin for Disorders Other Than Neuropathic Pain? |
| - | Review, | Var, | NA |
| 5858- | CAP, | Capsaicin as a Microbiome Modulator: Metabolic Interactions and Implications for Host Health |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 5856- | CAP, | Potential of capsaicin as a combinatorial agent to overcome chemoresistance and to improve outcomes of cancer therapy |
| - | Review, | Var, | NA |
| 5855- | CAP, | Unravelling the Mystery of Capsaicin: A Tool to Understand and Treat Pain |
| - | in-vivo, | Nor, | NA |
| 5854- | CAP, | Pharmacological activity of capsaicin: Mechanisms and controversies (Review) |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 5853- | CAP, | Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain |
| - | Review, | Var, | NA |
| 5852- | CAP, | Capsaicin Synergizes with Camptothecin to Induce Increased Apoptosis in Human Small Cell Lung Cancers via the Calpain Pathway |
| - | vitro+vivo, | NSCLC, | NA |
| 5851- | CAP, | Capsaicin Potentiates Anticancer Drug Efficacy Through Autophagy-Mediated Ribophorin II Downregulation and Necroptosis in Oral Squamous Cell Carcinoma Cells |
| - | in-vitro, | Oral, | NA |
| 5850- | CAP, | Anticancer Activity of Natural and Synthetic Capsaicin Analogs |
| - | Review, | Var, | NA |
| 5849- | CAP, | The Impact of TRPV1 on Cancer Pathogenesis and Therapy: A Systematic Review |
| - | Review, | Var, | NA |
| 5848- | CAP, | SRF, | Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation |
| - | in-vitro, | HCC, | HepG2 | - | in-vitro, | HCC, | HUH7 |
| 5847- | CAP, | An updated review on molecular mechanisms underlying the anticancer effects of capsaicin |
| - | in-vitro, | Liver, | HepG2 |
| 5846- | CAP, | Capsaicin Alters the Expression of Genetic and Epigenetic Molecules In Hepatocellular Carcinoma Cell |
| - | in-vitro, | HCC, | HepG2 |
| 5845- | CAP, | Unveiling the Molecular Mechanisms Driving the Capsaicin-Induced Immunomodulatory Effects on PD-L1 Expression in Bladder and Renal Cancer Cell Lines |
| - | in-vivo, | RCC, | A498 | - | in-vitro, | RCC, | T24/HTB-9 | - | NA, | Bladder, | 5637 |
| 5843- | CAP, | The Effects of Capsaicin on Gastrointestinal Cancers |
| - | Review, | GC, | NA |
| 5212- | CAP, | PI, | Chemo, | Capsaicin and Piperine Can Overcome Multidrug Resistance in Cancer Cells to Doxorubicin |
| - | in-vitro, | Colon, | Caco-2 |
| 5204- | CAP, | Low-concentration capsaicin promotes colorectal cancer metastasis by triggering ROS production and modulating Akt/mTOR and STAT-3 pathways |
| - | in-vitro, | Colon, | SW480 | - | in-vitro, | Colon, | CT26 |
| 5203- | CAP, | Capsaicin Promotes Apoptosis and Inhibits Cell Migration via the Tumor Necrosis Factor-Alpha (TNFα) and Nuclear Factor Kappa B (NFκB) Signaling Pathway in Oral Cancer Cells |
| - | in-vitro, | OS, | KB |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid